UE
UEEC.PK
—
OTC
Medical Equipment, Supplies & Distribution
Ueec.Pk
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
68,9 %
Net margin
—
Debt / equity
-0,52
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
UEEC.PK operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.
Business. UEEC.PK operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.
Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
68,9 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to UEEC.PK. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
UEEC.PK operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.
Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
AI synthesis
GENERATED— missing data
Key takeaways
- UEEC.PK is operating at a significant loss with no reported revenue.
- The company has a negative equity position and a high debt burden.
- Liquidity is critically low, with a current ratio of 0.03 and negative net cash.
- Profitability metrics are negative, indicating a lack of operational success.
- There is no segment or geographic data available to assess diversification.
- The company's financial position does not support growth or stability.
Bull / Bear case
analysis pipeline— missing data
In focus — financials by report
Valuation
Market price
$0,05
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
-$3.9M
Net cashⓘ
-$2.0M
Current ratioⓘ
0.0
Debt / equityⓘ
-0.5
ROAⓘ
-8.4%
ROEⓘ
68.9%
Cash conversionⓘ
44.0%
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
— missing data
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
ROE68,9 %Best in class
D/E-0,52Best in class
Cash Conv0,44Below median
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
Source documents
- UEEC.PK Market data — financials · 2026-05-29
Ownership & reference
Insider activity
— missing data
Short positioning
28.9Kshares short+32.6% vs prior
1days to cover
19.9Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
UEEC.PKCanonical
OTC · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data- Operating income (YoY) (2025-12-31 vs 2024-12-31): -12.3%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 17.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -58.6%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 0.7%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): -24.2%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): -1.08xDerived (calculated)
- Current ratio (FY 2025-12-31): 0.03xDerived (calculated)
- Return on assets (FY 2025-12-31): -842.9%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -33.4%Derived (calculated)
- Return on equity (FY 2025-12-31): 68.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 0.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 54.5%Derived (calculated)
- Current liabilities (annual): USD 3.94MSEC XBRL filing
- Current assets (annual): USD 105.39KSEC XBRL filing
- Shares outstanding (annual): 258.69MSEC XBRL filing
- Total liabilities (annual): USD 4.19MSEC XBRL filing
- Operating cash flow (annual): USD -1.19MSEC XBRL filing
- Total operating expenses (annual): USD 2.26MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
- Shareholders' equity (annual): USD -3.88MSEC XBRL filing
- Revenue (annual): USD 0SEC XBRL filing
- R&D expense (annual): USD 269.87KSEC XBRL filing
- Operating income (annual): USD -2.26MSEC XBRL filing
- Total assets (annual): USD 316.7KSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage